Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 23;9(4):1122-1126.
doi: 10.1016/j.ekir.2024.01.028. eCollection 2024 Apr.

Incidence of Common Glomerular Diseases Other Than Collapsing Glomerulopathy is Not Increased After SARS-CoV-2 Infection

Matthias Diebold  1 , Annette Enzler-Tschudy  2 , Birgit M Helmchen  3 , Helmut Hopfer  4 , Min Jeong Kim  5 , Solange Moll  6 , Giliane Nanchen  7 , Samuel Rotman  8 , Harald Seeger  9   10 , Andreas D Kistler  11   12
Affiliations

Incidence of Common Glomerular Diseases Other Than Collapsing Glomerulopathy is Not Increased After SARS-CoV-2 Infection

Matthias Diebold et al. Kidney Int Rep. .
No abstract available

Keywords: COVAN; COVID-19; SARS-CoV-2; glomerular disease; glomerulonephritis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expected and observed incidence of glomerulonephritis between January 2020 and August 2021 (upper panel: all 4 glomerular diseases together; lower panels: individual glomerular diseases). IgAN, IgA nephropathy; MCD, minimal change disease; MN, membranous nephropathy; PINGN, pauci-immune necrotizing glomerulonephritis. The observed incidence of glomerulonephritis in patients aged ≥18 years per million persons is shown in red. The expected incidence with a 95% credible interval is shown in green and green shading. The monthly incidence of SARS-CoV-2 infections per 1000 persons is shown in blue.
Figure 2
Figure 2
Frequency and timing of SARS-CoV-2 infection in patients with glomerulonephritis (GN) compared with matched controls. Grey bars represent the percentage of patients with a new diagnosis of IgA nephropathy, pauci-immune necrotizing glomerulonephritis, minimal change disease, or membranous nephropathy during the first 8 months of 2021, who reported a SARS-CoV-2 infection for each 4-week interval before the date of their kidney biopsy. Black bars represent the percentages of the controls from the general population matched for age and biopsy date with SARA-CoV-2 infection in the corresponding time interval.
See this image and copyright information in PMC

References

    1. Hirsch J.S., Ng J.H., Ross D.W., et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98:209–218. doi: 10.1016/j.kint.2020.05.006. - DOI - PMC - PubMed
    1. Sharma P., Uppal N.N., Wanchoo R., et al. COVID-19-associated kidney injury: a case series of kidney biopsy findings. J Am Soc Nephrol. 2020;31:1948–1958. doi: 10.1681/ASN.2020050699. - DOI - PMC - PubMed
    1. Velez J.C.Q., Caza T., Larsen C.P. COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19. Nat Rev Nephrol. 2020;16:565–567. doi: 10.1038/s41581-020-0332-3. - DOI - PMC - PubMed
    1. Shetty A.A., Tawhari I., Safar-Boueri L., et al. COVID-19-associated glomerular disease. J Am Soc Nephrol. 2021;32:33–40. doi: 10.1681/ASN.2020060804. - DOI - PMC - PubMed
    1. Wu H., Larsen C.P., Hernandez-Arroyo C.F., et al. AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype. J Am Soc Nephrol. 2020;31:1688–1695. doi: 10.1681/ASN.2020050558. - DOI - PMC - PubMed

LinkOut - more resources